SYMPOSIUM CO-CHAIRS
Samuel C. Blackman, MD, PhD
Chief Medical Officer & Co-Founder
Day One Biopharmaceuticals
Brenda Weigel, MD
Director of the Division of Pediatric Hematology/Oncology
University of Minnesota's Masonic Cancer Center
SESSION CHAIRS
Peter Adamson, MD
Sanofi
Elizabeth Fox, MD, MS
St. Jude Children's Research Hospital
Mark Kieran, MD, PhD
Bristol Myers Squibb
Sabine Mueller, MD, PhD
University of California, San Francisco
Lou Stancato, PhD
Eli Lilly and Company
Mark Turner, BSc, PhD, MBChB, MRCP(UK), MRCPCH, DRCOG, FFPM(Hon)
University of Liverpool, conect4children
SPEAKERS BY SESSION
Expanding the Global Footprint of Pediatric Oncology Trials
-
Derek Ansel, MS, CCRA
Worldwide Clinical Trials
-
Guillermo Chantada, MD
Hospital Sant Joan de Déu Barcelona
-
Sae Ishimaru, MD, PhD
Princess Maxima Center
-
Chi-kong Li, MBBS, MD, FRCPCH, FHKAM (Paediatrics), JP
The Chinese University of Hong Kong
-
Heidi Wang, PhD
Bristol Myers Squibb
Real-World Data and Synthetic Control Arms
-
Pallavi Mishra-Kalyani, PhD
U.S. Food and Drug Administration -
Samuel Volchenboum, MD, PhD
University of Chicago -
Barbara Arone, MS
IQVIA Real World Solutions
Pharmacokinetics in pediatric clinical trial design: How do we find the “right” dose?
-
Gilbert J. Burckart, PharmD
U.S. Food and Drug Administration -
Gareth Veal, PhD
Newcastle University -
S.Y. Amy Cheung, PhD
Certara
Clinical Trials with Combination Therapies
-
Cassie Kline, MD, MS
Children’s Hospital of Philadelphia -
Jeffrey Skolnik, MD
Inovio Pharmaceuticals, Inc. -
Elizabeth R. Lawlor, MD, PhD
Seattle Children’s Hospital
Decentralized Clinical Trials
-
Isaac R. Rodriguez-Chavez, PhD, MHSc, MSc
ICON plc.
Regulators Dish
-
Gregory Reaman, MD
U.S. Food and Drug Administration -
Dominik Karres, MD
European Medicines Agency
Please check in regularly as we update our speaker list.